Show‐Li Chen
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Peroxisome Proliferator-Activated Receptors 5
- Muscle Physiology and Disorders 5
- RNA Research and Splicing 5
- Ubiquitin and proteasome pathways 5
- Epidemiology 12
- Cervical Cancer and HPV Research 8
- Co-authors
- Yeou‐Ping Tsao (58 shared papers)Tsung‐Chuan Ho (23 shared papers)Huey-Chuan Cheng (9 shared papers)Yuh‐Cheng Yang (6 shared papers)Jui-Wen Hsieh (5 shared papers)Shou‐Chuan Shih (5 shared papers)Ping‐Chang Kuo (6 shared papers)Shu‐I Yeh (8 shared papers)
- Journals
- PLoS ONE (4 papers)Journal of Cachexia Sarcopenia and Muscle (3 papers)Biochemical and Biophysical Research Communications (3 papers)Cancer Letters (3 papers)Journal of Virology (3 papers)
- Partner nations
- TaiwanUnited StatesFrance
In The Last Decade
Show‐Li Chen
65 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Ophthalmology 162
- Immunology 266
- Molecular Biology 690
- Epidemiology 274
- Genetics 213
Countries citing papers authored by Show‐Li Chen
This map shows the geographic impact of Show‐Li Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Show‐Li Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Show‐Li Chen more than expected).
Fields of papers citing papers by Show‐Li Chen
This network shows the impact of papers produced by Show‐Li Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Show‐Li Chen. The network helps show where Show‐Li Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Show‐Li Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 86 | |
| 2 | 2010 | 76 | |
| 3 | 2000 | 65 | |
| 4 | 2000 | 60 | |
| 5 | 2000 | 59 | |
| 6 | 2013 | 57 | |
| 7 | 2004 | 54 | |
| 8 | 2002 | 52 | |
| 9 | 2006 | 51 | |
| 10 | 2010 | 40 | |
| 11 | 2007 | 39 | |
| 12 | 2006 | 37 | |
| 13 | 2011 | 36 | |
| 14 | 2009 | 35 | |
| 15 | 2008 | 34 | |
| 16 | Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells. | 2008 | 32 |
| 17 | 2014 | 32 | |
| 18 | 2015 | 32 | |
| 19 | 1993 | 32 | |
| 20 | 2005 | 32 |
About Show‐Li Chen
Show‐Li Chen is a scholar working on Molecular Biology, Epidemiology, Genetics, Immunology and Hepatology, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), Cervical Cancer and HPV Research (8 papers), Immunotherapy and Immune Responses (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Muscle Physiology and Disorders (5 papers), Cancer-related Molecular Pathways (5 papers), RNA Research and Splicing (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Ophthalmology (162 citations), Immunology (266 citations), Molecular Biology (690 citations), Epidemiology (274 citations) and Genetics (213 citations). Show‐Li Chen has collaborated with scholars based in Taiwan, United States and France. Frequent co-authors include Yeou‐Ping Tsao, Tsung‐Chuan Ho, Huey-Chuan Cheng, Yuh‐Cheng Yang, Jui-Wen Hsieh, Shou‐Chuan Shih, Ping‐Chang Kuo, Shu‐I Yeh, Yifang Chen and Chih-Wei Lin. Their work appears in journals such as PLoS ONE, Journal of Cachexia Sarcopenia and Muscle, Biochemical and Biophysical Research Communications, Cancer Letters and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.